Pushpa Singh1,2, Nicola Adderley3, Anuradhaa Subramanian3, Krishna Gokhale3, Rishi Singhal4, Konstantinos A Toulis3,5, Srikanth Bellary2,6, Krishnarajah Nirantharakumar7,3,8,9, Abd A Tahrani1,2,8. 1. Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, U.K. 2. Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K. 3. Institute of Applied Health Research, University of Birmingham, Birmingham, U.K. 4. Department of Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, U.K. 5. Department of Endocrinology, 424 General Army Training Hospital, Thessaloniki, Greece. 6. School of Life and Health Sciences, Aston University, Birmingham, U.K. 7. Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K. k.nirantharan@bham.ac.uk. 8. Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, U.K. 9. Midlands Health Data Research, Birmingham, U.K.
Abstract
OBJECTIVE: To assess the impact of bariatric surgery (BS) on incident microvascular complications of diabetes-related foot disease (DFD), sight-threatening diabetic retinopathy (STDR), and chronic kidney disease (CKD) in patients with type 2 diabetes and obesity. RESEARCH DESIGN AND METHODS: A retrospective matched, controlled population-based cohort study was conducted of adults with type 2 diabetes between 1 January 1990 and 31 January 2018 using IQVIA Medical Research Data (IMRD), a database of primary care electronic records. Each patient with type 2 diabetes who subsequently had BS (surgical group) was matched on the index date with up to two patients with type 2 diabetes who did not have BS (nonsurgical group) within the same general practice by age, sex, preindex BMI, and diabetes duration. RESULTS: Included were 1,126 surgical and 2,219 nonsurgical participants. In the study population 2,261 (68%) were women. Mean (SD) age was 49.87 (9.3) years vs. 50.12 (9.3) years and BMI was 46.76 (7.96) kg/m2 vs. 46.14 (7.49) kg/m2 in the surgical versus nonsurgical group, respectively. In the surgical group, 22.1%, 22.7%, 52.2%, and 1.1% of patients had gastric band, sleeve gastrectomy, Roux-en-Y gastric bypass (RYGB), and duodenal switch, respectively. Over a median follow-up of 3.9 years (interquartile range 1.8-6.4), BS was associated with reduction in incident combined microvascular complications (adjusted hazard ratio 0.53, 95% CI 0.43-0.66, P < 0.001), DFD (0.61, 0.50-0.75, P < 0.001), STDR (0.66, 0.44-1.00, P = 0.048), and CKD (0.63, 0.51-0.78, P < 0.001). Analysis based on the type of surgery showed that all types of surgery were associated with a favorable impact on the incidence of composite microvascular complications, with the greatest reduction for RYGB. CONCLUSIONS: BS was associated with a significant reduction in incident diabetes-related microvascular complications.
OBJECTIVE: To assess the impact of bariatric surgery (BS) on incident microvascular complications of diabetes-related foot disease (DFD), sight-threatening diabetic retinopathy (STDR), and chronic kidney disease (CKD) in patients with type 2 diabetes and obesity. RESEARCH DESIGN AND METHODS: A retrospective matched, controlled population-based cohort study was conducted of adults with type 2 diabetes between 1 January 1990 and 31 January 2018 using IQVIA Medical Research Data (IMRD), a database of primary care electronic records. Each patient with type 2 diabetes who subsequently had BS (surgical group) was matched on the index date with up to two patients with type 2 diabetes who did not have BS (nonsurgical group) within the same general practice by age, sex, preindex BMI, and diabetes duration. RESULTS: Included were 1,126 surgical and 2,219 nonsurgical participants. In the study population 2,261 (68%) were women. Mean (SD) age was 49.87 (9.3) years vs. 50.12 (9.3) years and BMI was 46.76 (7.96) kg/m2 vs. 46.14 (7.49) kg/m2 in the surgical versus nonsurgical group, respectively. In the surgical group, 22.1%, 22.7%, 52.2%, and 1.1% of patients had gastric band, sleeve gastrectomy, Roux-en-Y gastric bypass (RYGB), and duodenal switch, respectively. Over a median follow-up of 3.9 years (interquartile range 1.8-6.4), BS was associated with reduction in incident combined microvascular complications (adjusted hazard ratio 0.53, 95% CI 0.43-0.66, P < 0.001), DFD (0.61, 0.50-0.75, P < 0.001), STDR (0.66, 0.44-1.00, P = 0.048), and CKD (0.63, 0.51-0.78, P < 0.001). Analysis based on the type of surgery showed that all types of surgery were associated with a favorable impact on the incidence of composite microvascular complications, with the greatest reduction for RYGB. CONCLUSIONS: BS was associated with a significant reduction in incident diabetes-related microvascular complications.
Authors: A T Billeter; K M Scheurlen; P Probst; S Eichel; F Nickel; S Kopf; L Fischer; M K Diener; P P Nawroth; B P Müller-Stich Journal: Br J Surg Date: 2018-02 Impact factor: 6.939
Authors: Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel Journal: Circulation Date: 2005-12-27 Impact factor: 29.690
Authors: P Singh; A Subramanian; N Adderley; K Gokhale; R Singhal; S Bellary; K Nirantharakumar; A A Tahrani Journal: Br J Surg Date: 2020-01-21 Impact factor: 6.939
Authors: Edward W Gregg; Yanfeng Li; Jing Wang; Nilka Rios Burrows; Mohammed K Ali; Deborah Rolka; Desmond E Williams; Linda Geiss Journal: N Engl J Med Date: 2014-04-17 Impact factor: 91.245
Authors: Hind El Ouardighi; Kris G Poppe; Pierre Kleynen; Lidia Grabzcan; Flora Veltri; Anne Violette Bruyneel; Pham Anh Hong Nguyen; Marie Bruyneel Journal: Sleep Breath Date: 2022-02-09 Impact factor: 2.816
Authors: Zhaonan Wang; Jonathan Hazlehurst; Anuradhaa Subramanian; Abd A Tahrani; Wasim Hanif; Neil Thomas; Pushpa Singh; Jingya Wang; Christopher Sainsbury; Krishnarajah Nirantharakumar; Francesca L Crowe Journal: Front Endocrinol (Lausanne) Date: 2022-07-11 Impact factor: 6.055